Literature DB >> 22126250

Disturbed methylation at multiple imprinted loci: an increasing observation in imprinting disorders.

Thomas Eggermann1, Isabelle Leisten, Gerhard Binder, Matthias Begemann, Sabrina Spengler.   

Abstract

The widely accepted association between aberrant methylation at specific imprinted loci and distinct imprinting disorders has recently been brought into question by the identification of methylation defects at multiple loci (multilocus methylation defect [MLMD]). Strikingly, in different imprinting disorders, the same MLMD patterns can be observed. The cause for this ambiguous epigenotype-phenotype correlation is currently unknown. Future strategies to solve this enigma have to include all levels of imprinting regulation, ranging from DNA methylation to chromatin organization, as any disturbance of the balanced interaction between the different players in imprinting regulation might cause disturbed expression of imprinted factors. The molecular analysis of MLMD will help in discovering these interactions and contribute to the understanding of genomic imprinting and its disturbances.

Mesh:

Year:  2011        PMID: 22126250     DOI: 10.2217/epi.11.84

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  9 in total

Review 1.  Imprinted Zac1 in neural stem cells.

Authors:  Guillaume Daniel; Udo Schmidt-Edelkraut; Dietmar Spengler; Anke Hoffmann
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 2.  Abnormalities of the DNA methylation mark and its machinery: an emerging cause of neurologic dysfunction.

Authors:  Jacqueline Weissman; Sakkubai Naidu; Hans T Bjornsson
Journal:  Semin Neurol       Date:  2014-09-05       Impact factor: 3.420

3.  Genome-wide paternal uniparental disomy mosaicism in a woman with Beckwith-Wiedemann syndrome and ovarian steroid cell tumour.

Authors:  Magdalena Gogiel; Matthias Begemann; Sabrina Spengler; Lukas Soellner; Ulf Göretzlehner; Thomas Eggermann; Gertrud Strobl-Wildemann
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

4.  Genome-wide methylation analysis in Silver-Russell syndrome patients.

Authors:  A R Prickett; M Ishida; S Böhm; J M Frost; W Puszyk; S Abu-Amero; P Stanier; R Schulz; G E Moore; R J Oakey
Journal:  Hum Genet       Date:  2015-01-07       Impact factor: 4.132

5.  Genome-wide DNA methylation analysis of patients with imprinting disorders identifies differentially methylated regions associated with novel candidate imprinted genes.

Authors:  Louise E Docherty; Faisal I Rezwan; Rebecca L Poole; Hannah Jagoe; Hannah Lake; Gabrielle A Lockett; Hasan Arshad; David I Wilson; John W Holloway; I Karen Temple; Deborah J G Mackay
Journal:  J Med Genet       Date:  2014-02-05       Impact factor: 6.318

6.  Decreased expression of cell proliferation-related genes in clonally derived skin fibroblasts from children with Silver-Russell syndrome is independent of the degree of 11p15 ICR1 hypomethylation.

Authors:  Doreen Heckmann; Christina Urban; Karin Weber; Kai Kannenberg; Gerhard Binder
Journal:  Clin Epigenetics       Date:  2015-01-22       Impact factor: 6.551

7.  Novel multilocus imprinting disturbances in a child with expressive language delay and intellectual disability.

Authors:  Marwan K Tayeh; Janean DeVaul; Kristin LeSueur; Chen Yang; Jirair K Bedoyan; Peedikayil Thomas; Mark C Hannibal; Jeffrey W Innis
Journal:  Am J Med Genet A       Date:  2022-04-01       Impact factor: 2.578

Review 8.  Clinical significance of copy number variations in the 11p15.5 imprinting control regions: new cases and review of the literature.

Authors:  Matthias Begemann; Sabrina Spengler; Magdalena Gogiel; Ute Grasshoff; Michael Bonin; Regina C Betz; Andreas Dufke; Isabel Spier; Thomas Eggermann
Journal:  J Med Genet       Date:  2012-07-26       Impact factor: 6.318

9.  DNA methylation as clinically useful biomarkers-light at the end of the tunnel.

Authors:  Victor V Levenson; Anatoliy A Melnikov
Journal:  Pharmaceuticals (Basel)       Date:  2012-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.